Objective: To determine the effect of presence of high concentrations of nicotinamide adenine dinucleotide (NADH)-and nicotinamide adenine dinucleotide phosphate (NADPH)-consuming enzymes on the accuracy of glutamate dehydrogenase (GLDH) assay for ammonia.
The most widely used analytical method for determining plasma ammonia concentration in routine laboratories worldwide is an enzymatic method based on the specific conversion of reduced form of nicotinamide adenine dinucleotide (NADH) It is assumed that the reduction in the absorbance at 340 nm caused by the oxidation of NADH or NADPH is directly proportionate to the ammonia concentration. [1] [2] [3] However, nonspecific coenzyme oxidation caused by substances in specimen matrices may arise in the analysis. At present, the use of NADPH is given preference because of its negligible nonspecific oxidation in the assay mixture, compared with NADH. [4] [5] [6] There are various problems in determining ammonia concentration related to preanalytical factors such as phlebotomy technique, specimen handling, centrifugation temperature, and contamination of specimens with ammonia. 7, 8 The presence of hemolysis causes an increase in the hemoglobin concentration, which absorbs approximately 340 nm, and thus affects methods based on NADH/ NADPH absorbance properties. 9, 10 The substantial influence on the accuracy measurement of plasma ammonia levels may have activities of various enzymes, such as alanine transaminase, lactate dehydrogenase, GLDH, gamma glutamyl transferase, malate dehydrogenase, and isocitrate dehydrogenase. All of these enzymes require NADH and/or NADPH and therefore give rise to chemical reactions, which can affect the results. 3, 8, 11, 12 In particular, a marked increase in the plasma concentrations of these enzymes occurs in acute liver injury due to the leakage of these enzymes from dying hepatocytes into the circulation. 13 To our knowledge, there have been no studies examining the accuracy of ammonia measurements under these conditions.
The main objective of this study was to examine the accuracy of the GLDH method for measuring of ammonia concentrations in blood plasma with low and high concentrations of NADH-and NADPH-consuming enzymes. For this purpose, we measured ammonia levels in blood-plasma specimens from healthy rats and rats with acute liver injury; we also measured these levels in specimens from which the enzymes were removed by sulfosalicylic acid-mediated protein precipitation. The effects of these enzymes on NADH/ NADPH oxidation were also examined in reaction mixtures without GLDH by recording the changes in absorbance at 340 nm.
Materials and Methods
In this study, we used Male Wistar rats (body weight, 220 g-250 g) obtained from Velaz Ltd. The rats were housed in standardized cages in quarters with controlled temperature under a 12-hour light-dark cycle and received standard food and water as they desired. All of the procedures involving these rats were performed in accordance with guidelines set by the Institutional Animal Care and Use Committee of Charles University (license no. 144879/2011-MZE-17214). Chemicals were obtained from Sigma Chemical Company and Bio-Rad Laboratories Inc.
Study Protocol
The rats (n = 18) were randomly divided into 2 groups, each of which received 3 g of CCl 4 per kg of body weight diluted 1:1 in olive oil (study group) or olive oil only by oral gavage (controls). The rats were kept in a fasting state until they were killed via exsanguination from the abdominal aorta in ether anesthesia at 24 hours after treatment. The blood was drawn into a K 2 ethylenediaminetetraacetic acid (EDTA) tube (S-Monovette ; Sarstedt AG & Co) and centrifuged immediately at 2200 g for 15 minutes at 0°C. Half of the blood-plasma specimens were deproteinized with 0.3 M sulfosalicylic acid (1:1, volume/volume) and centrifuged at 12,000 g for 5 minutes at 4°C. The supernatant was neutralized with 0.1M tris(hydroxymethyl)aminomethane (TRIS) buffer to a pH of 7.8.
Ammonia concentrations were measured in blood plasma and deproteinized specimens within 3 hours after blood collection. The specimens were kept in an ice bath until analysis. Urine and ammonia compounds were excluded from specimen proximity to prevent ammonia contamination. We cleaned and washed glassware with ammonia-free water before use. The specimens taken to estimate the effects of hepatic enzymes on NADH and NADPH oxidation were kept at −80 °C until analysis. The study protocol is shown in Figure 1 .
Ammonia Concentration
The ammonia concentration was measured as described in the technical bulletin for the ammonia assay kit (Sigma Chemical Co). We added 50 µL of the specimen to 500 µL of reaction mixture containing 3.4 mM 2-oxoglutarate and 0.23 mM NADPH or NADH in 0.1M TRIS buffer (pH, 8.0) and incubated at mean (SE) 25°C (2°C) for 10 minutes. Then, the absorbance was recorded at 340 nm using a Tecan Infinite 200 plate reader (Tecan GmbH) before and 15 minutes after adding GLDH. The measurements were corrected against the corresponding blank prepared exactly in the same way without addition of plasma or deproteinized plasma specimens. The differences between the initial and final absorbance values were used to calculate the ammonia concentrations. The water and reagents were free of ammonia.
Nonspecific Oxidation of NADH and NADPH
We examined the nonspecific oxidation of NADH and NADPH in the reaction mixtures as described for the ammonia measurement but without the addition of GLDH. The decrease in the absorbance was recorded at 4-minute intervals, up to 32 minutes. The results were expressed as the percentage decrease in the absorbance at 340 nm compared with the initial absorbance at the same wavelength.
Enzyme Activities
We measured alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), and GLDH activities using commercial kits from Biosystems S.A. and Randox Laboratories.
Statistical Analysis
We used the Mann-Whitney U test to compare the enzyme activities in blood plasma. Changes in spontaneous oxidation levels were described with regression line slopes based on weighted least squares estimates (WLS), with the weights being inversely proportional to the variance. Test differences between the slopes used t criteria and P values. Before performing 1-way analysis of variance (ANOVA) tests of equality for ammonia mean values, we performed Shapiro-Wilk testing for normality. The results were expressed as mean (SE). Differences were considered significant at an adjusted P <.05 (after Bonferroni correction). We used IBM SPSS Statistics software, version 24.0, (IBM Corporation) for calculations.
Results
Blood plasma enzyme activities indicating acute liver injury increased markedly at 24 hours after CCl 4 treatment ( Table  1) . We observed a gradual decrease in the absorbance, indicating nonspecific oxidation of both coenzymes, in blood plasma from CCl 4 -treated rats and after the addition of NADH to the control-group specimens. No decrease in the nonspecific oxidation of NADPH was observed in the control specimens (the slope was not significantly different from 0). The regression lines for the CCl 4 and control groups (with slopes significantly different from 0) displayed statistically significantly different slopes. An increase in the variance with time was detected. The mean (SE) decrease
Figure 1
Study protocol. NADPH indicates nicotinamide adenine dinucleotide phosphate (reduced form); NADH, nicotinamide adenine dinucleotide (reduced form). in the absorbance in blood plasma obtained from CCl 4 -treated rats was 13.2% (3.68%) and 5.2% (1.27%) at 32 minutes after the addition of NADH and NADPH, respectively ( Figure 2 and Table 2 ). We detected no trends in the changes in the absorbance and no statistically significant differences in the decreases in absorbance in the deproteinized specimens (no statistically significant differences among the slopes were found at P <.05) ( Figure 3 and Table 3 ). Figure 4 shows that neither deproteinization nor the coenzyme type used in the analysis affected the ammonia measurement results in the specimens from control rats. The values for the ammonia concentration in the CCl 4 -treated rat specimens were lower in the deproteinized specimens compared with the blood-plasma specimens. Also, we observed no statistically significant effects based on the type of coenzyme used for the analysis.
Discussion
Poisoning with CCl 4 is a widely used model to study the effects of hepatic injury. We believe that our results can be applied in clinical practice, although the etiology of liver injury induced by CCl 4 is not typically observed in humans. 
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Figure 2
Nonspecific oxidation of reduced forms of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotide phosphate (NADPH) in blood-plasma specimens from control and CCl 4 -treated rats. Values are expressed as mean (SE) (n = 9).
A single dose of CCl 4 leads promptly to centrizonal necrosis and steatosis. Massive necrosis and the highest concentrations of hepatic enzymes released from damaged hepatocytes are achieved at 24 hours.
14 Therefore, at this time,
we studied the effects of NADH-and NADPH-consuming enzymes on the accuracy of GLDH assay for ammonia.
Investigators da Fonseca-Wollheim and Heinz 4 and van
Anken and Schiphorst 6 reported that 2´-phosphorylated coenzyme (NADPH) is oxidized less than the unphosphorylated form (NADH) and recommended the use of NADPH instead of NADH for measuring plasma ammonia concentrations using GLDH. This suggestion agreed with our finding of smaller decreases in the blood-plasma absorbance values from specimens from healthy rats after adding NADPH, compared with the decreases after adding NADH. However, we observed a marked decrease in absorbance (indicating nonspecific coenzyme oxidation) after adding NADH and NADPH into blood-plasma specimens obtained from CCl 4 -treated rats. The decrease in absorbance was statistically significantly smaller after adding NADPH, compared with the decrease after adding NADH. However, the results clearly showed that using NADPH instead of NADH does not resolve the problem of adverse effect of increased levels of liver enzymes in testing of ammonia values using the GLDH assay.
It has been suggested 6, 15 that preincubation of the specimen with NADH/NADPH could eliminate the nonspecific 
Figure 3
Nonspecific oxidation of reduced forms of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotide phosphate (NADPH) in deproteinized plasma specimens from control and CCl 4 -treated rats. Values are expressed as mean (SE) (n = 9). Our study results clearly demonstrate that the marked decrease in absorbance after the addition of NADH and NADPH to blood plasma in CCl 4 -treated rats is not observed in deproteinized specimens. This finding provides clear evidence that the ammonia measurement accuracy problem in liver injury can be solved by specimen deproteinization. Lower ammonia values in deproteinized specimens compared with nondeproteinized specimens indicate that the current ammonia assay overestimates the true ammonia values in rats with liver disease. Our findings indicate that this finding is due to the additional consumption of NADH and NADPH by high levels of NADH-consuming and NADPH-consuming enzymes released from dying hepatocytes. Deproteinization of the specimens also eliminates the possible interference of the effect of lactic acid, which is frequently high in liver injury due to reduced hepatic clearance. At high concentrations of lactate, LDH exhibits feedback inhibition, and the rates of conversion of pyruvate to lactate and NADH and NADPH to NAD and NADP are decreased.
Various chemicals can be used for biological specimen deproteinization. The most common chemicals are perchloric acid (logarithm of dissociation constant [pKa] ~1), trichloracetic acid (pKa ~1), and sulfosalicylic acid (pKa ~2.85). However, deproteinization with strong acids, such as perchloric acid and trichloracetic acid, enhances ammonia release from glutamine hydrolysis and can therefore lead to overestimation of the results. 16, 17 We have used sulfosalicylic acid, which is commonly used as a deproteinization agent for amino-acid analysis in blood plasma. Stability measurements in specimens deproteinized using sulfosalicylic acid have shown that the glutamine concentration did not differ compared with values obtained 1 day after specimen collection in specimens stored for 10 days at −20°C.
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Conclusions
There is widespread scientific consensus that ammonia plays a main role in the pathogenesis of hepatic encephalopathy. Thus, measuring its plasma concentration should be a fundamental type of laboratory examination in patients with liver disease. Our results clearly demonstrate that the present enzymatic method used to measure ammonia concentrations is inaccurate when high concentrations of NADH-consuming and NADPH-consuming enzymes are present in the examined specimen. The accuracy of these measurements can be significantly enhanced by specimen deproteinization with sulfosalicylic acid. Under this condition, there are no differences in the accuracies of the results obtained using NADH or NADPH as the coenzyme. We believe that our findings are comparable to conditions observed in humans with liver injury caused by etiologies other than CCl 4 . Extremely high levels of enzymes indicating hepatocellular injury, as observed in our model, might be present in people with acute toxic or viral hepatitis, ischemia-reperfusion injury, and exposure to industrial solvents such as CCl 4 . 19 The interference of NADH-and
Figure 4
Results of ammonia-concentration measurements using reduced forms of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotide phosphate (NADPH) in blood plasma and deproteinized specimens from control and CCl 4 -treated animals. * indicates P <.05. Values are expressed as mean (SE) (n = 9)
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NADPH-consuming enzymes is likely to be negligible in mild forms of liver damage. LM
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